We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Menstrual Blood Testing With Capture Sequencing Detects High-Risk Human Papillomavirus

By LabMedica International staff writers
Posted on 04 Jan 2022
Persistent infection of high-risk human papillomavirus (hrHPV) is associated with various HPV-related pre-cancers and cancers. More...
In recent years, HPV testing has gradually become the primary method for cervical cancer screening.

Self-sampling HPV testing is a proposed alternative cervical cancer screening for avoiding stigma and improving participation. Most existing self-sampling HPV studies were based on various sampling brushes inserted into the vagina, and patients may experience discomfort during sampling. Compared with these methods, menstrual blood (MB) collection is associated with less stigma and pain.

Gynecologists at the Sun Yat-sen University (Guangzhou, China) and their colleagues recruited women who were premenopausal and had tested positive for hrHPV in the Central Hospital of Wuhan (Wuhan, China), from September 1, 2020, to April 1, 2021. Cervical smears were collected from recruited patients by an experienced gynecologist. Self-provided commercial sanitary pads were used to collect MB from enrolled patients. A total of 120 enrolled women with hrHPV (mean [SD; range] age, 33.9 [6.9; 20.0 -52.0] years) provided 137 sanitary pads.

A commercial Tiangen dried blood spot DNA extraction kit (Tiangen Biotech, Beijing, China) was used to extract MB DNA from sanitary pads. The concentration of DNA was confirmed using the Qubit 4.0 fluorometer and Qubit dsDNA high-sensitivity (HS) assay kit (Thermo Fisher Scientific, Waltham, MA, USA), and the purity of DNA was determined by Thermo Fisher Scientific’s NanoDrop One spectrophotometer. Extracted MB DNA was stored at −20 °C. Sequencing was performed using a NovaSeq PE150 (Illumina, San Diego, CA, USA). The 21 HPV GenoArray (GA) test (Hybribio Ltd., Hong Kong, China) was used for genotyping.

The investigators reported that the overall concordance rate of MB hrHPV capture sequencing and cervical HPV testing was 92.7, with a κ value of 0.763. Among 24 samples with incomplete concordance or discordant results, 11 samples with additional hrHPV genotypes (45.8%), five true-negative samples (20.8%), and the correct hrHPV genotypes of two samples (8.3%) were correctly identified by MB hrHPV capture sequencing. MB hrHPV detection of hrHPV was equivalent on different menstrual cycle days (MCDs), with an MB hrHPV–positive rate of 27/28 patients (96.4%) for MCD 1, 52/57 patients (91.2%) for MCD 2, 27/28 patients for MCD 3, 4/4 of patients (100%) for MCD 4, and 3/3 patients (100%) for MCD 5. The sensitivity of the MB hrHPV capture sequencing was 97.7%.

The authors concluded that MB hrHPV capture sequencing is a feasible and accurate self-collected approach for cervical cancer screening. This study found that this method is associated with superior performance in identification of HPV genotypes and true-negative events compared with cervical HPV testing. The study was published on December 23, 2021 in the journal JAMA Network Open.

Related Links:
Sun Yat-sen University
Central Hospital of Wuhan
Tiangen Biotech
Thermo Fisher Scientific
Illumina
Hybribio Ltd



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.